| Entries |
| Document | Title | Date |
|---|
| 20080200858 | BLOOD DIAGNOSIS METHOD FOR DIALYSIS PATIENT AND DIALYSIS MACHINE - Provided is a blood diagnosis method of providing a diagnostic marker which is general and which contributes to dialysis treatment and evaluation of clinical effects. The method includes a step of collecting blood samples from a dialysis patient before and/or after dialysis and a step of performing a gene diagnosis based on mRNA markers on the collected blood samples. The mRNA markers are previously identified on the basis of correlations between clinical data and mRNA profiles. | 08-21-2008 |
| 20080208102 | CIRCUIT FOR EXTRACORPOREAL BLOOD TREATMENT AND FLOW-INVERTING DEVICE THEREIN - It is disclosed a circuit for extracorporeal blood treatment in which a flow-inverting device is interposed between a blood treatment unit and a blood pump placed on an artery branch connected with a vascular access of a patient. The flow-inverting device allows the blood flow within the filtering unit to be kept unchanged even following an inverted circulation in the patient-side artery and vein branches controlled by the blood pump. | 08-28-2008 |
| 20080214978 | METHOD OF TREATING A BODILY FLUID - A method of treating a bodily fluid withdrawn and then returned to a living body. The method involves withdrawing the bodily fluid from the living body and causing the bodily fluid to flow through a treatment system, altering at least the density of the bodily fluid through the action of a second fluid as the bodily fluid flows through the treatment system, sensing at least the density and flow rate of the bodily fluid before the density thereof is altered by the second fluid, sensing at least the density and flow rate of the bodily fluid after the density thereof is altered by the second fluid, sensing at least the density and flow rate of the second fluid, controlling the density and/or flow rate of the second fluid based on the sensed densities and flow rates, and returning the bodily fluid to the living body. | 09-04-2008 |
| 20080234620 | METHOD OF MONITORING THE OPERATIONALITY OF A FLOW CUT-OFF MEMBER AND FLOW ARRESTING SYSTEM, FOR AN EXTRACORPOREAL FLUID CIRCUIT - A description is given of a method of monitoring the operationality of a flow cut-off member for an extracorporeal fluid circuit. Also described is a system for arresting the flow of blood that implements this monitoring method. The system has a flow cut-off member active on a radially deformable length of tube forming part of the circuit, and a unit capable of causing a movement of a movable portion of the cut-off member towards a closed condition. The system detects when the movable portion passes through a first predetermined position and determines the value assumed by a dynamic parameter associated with the motion of the movable portion at the first predetermined position. The system further checks that this value is within a predetermined criterion of acceptability. Lastly, a blood treatment appliance is described that implements the described method and system. | 09-25-2008 |
| 20080281247 | Autonomic nervous activity monitor, blood processing apparatus, blood collecting apparatus and autonomic nervous activity monitoring method - An autonomic nervous activity monitor capable of predicting occurrence of abnormal reaction depending on autonomic nervous activity and used for medical practice and the like is provided. A blood component collecting apparatus | 11-13-2008 |
| 20090005719 | Blood Treatment Device Comprising Rod-Shaped Means for Holding Articles - The invention relates to the field of blood treatment machines with a blood treatment module to hold components of an extracorporeal blood circulation. To simplify access to a securing means ( | 01-01-2009 |
| 20090048552 | METHODS AND DEVICES FOR REMOVAL OF A MEDICAL AGENT FROM A PHYSIOLOGICAL EFFERENT FLUID COLLECTION SITE - Methods and devices for selectively removing an agent from a physiological site, e.g., a physiological efferent fluid collection site, are provided. Aspects of the invention include fluid removal (e.g., aspiration) devices having a fluid removal element and a flow modulator positioned at a distal end of the fluid removal element. The flow modulator is configured to converge intersecting fluid flow paths into the fluid removal element. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites. | 02-19-2009 |
| 20090105628 | EXTRACORPOREAL ULTRASONIC MEDICAL DEVICE - Ultrasonic devices for preventing microbubbles and/or microparticles from reaching the brain during a PCI or cardiovascular surgery. Devices | 04-23-2009 |
| 20090171261 | METHOD AND APPARATUS FOR CALCULATING FLUID FLOW RATE - A switch valve for use in an extracorporeal blood flow circuit comprises a valve housing having a chamber, four openings communicating with the chamber, and a valve member located in the valve chamber. A first opening is to be connected to a patient via an arterial cannula, a second opening is to be connected to a patient via an venous cannula, a third opening is to be connected to a first inlet/outlet of a blood treatment device, and a fourth opening is to be connected to a second inlet/outlet of a blood treatment device. The valve member is movable within the valve housing to fluidly connect the first opening to either the third or the fourth opening and to fluidly connect the second opening to either the third or the fourth opening. The width of the valve member is smaller than a peripheral dimension of the openings. | 07-02-2009 |
| 20090306572 | New Polypeptides, uses thereof and methods employing it - A TNF-α binding polypeptide is provided, which is related to a domain of staphylococcal protein A (SPA) in that the sequence of the polypeptide corresponds to the sequence of the SPA domain having 1 to about 20 substitution mutations. Nucleic acid encoding the polypeptide, expression vector comprising the nucleic acid, and host cell comprising the expression vector are also provided. Also provided are methods comprising a step of affinity separation or detection, in which step a polypeptide according to the invention is used. Such methods may be used for reducing the content of TNF-α in a body fluid. | 12-10-2009 |
| 20090306573 | Remote Controlled Medical Apparatus - The invention relates to remote controlled blood cleaning of a patient (P). A dialysis unit ( | 12-10-2009 |
| 20100016776 | TREATMENT DEVICE WITH MEMORY-SUPPORTED CONTROL MEANS - The therapy device stores the time profiles of the blood pressure and of other influencing variables during preceding therapy procedures. The time profile of the blood pressure and of other influencing variables during the actual therapy is also recorded. An analytical comparison is then made between the time profiles of the blood pressure and of other influencing variables during the actual measurement procedure and those during preceding therapy procedures. Depending on the comparison, a prospective blood pressure control is carried out in order to prevent drops in blood pressure in a subsequent time period. | 01-21-2010 |
| 20100022934 | SYSTEM AND METHOD FOR DETECTING ACCESS DISCONNECTION - A dialysis system includes: a blood filter; a dialysate pump connected to a dialysate portion of the blood filter; a blood pump connected to a blood portion of the blood filter, the blood pump including a diaphragm that is moved in cycles to pump the blood, the cycles having a flow period and a no-flow period; a patient access device in fluid communication with the blood portion of the blood filter, the no-flow period having a first characteristic of a property when the patient access device is lodged in a patient and a second characteristic of the property when the patient access device is dislodged from the patient; and a logic implementer configured to determine that the patient access device has been dislodged from the patient when the second characteristic of the parameter is detected. | 01-28-2010 |
| 20100106071 | BLOOD TREATMENT APPARATUS - A blood treatment apparatus ( | 04-29-2010 |
| 20100130904 | METHOD TO INHIBIT PROLIFERATION AND GROWTH OF METASTASES - The present invention provides a method to reduce the amount of undesired growth factors in the circulating blood of a subject to prevent tumor growth and proliferation during or after a wound healing and/or other local tissue repair process on a subject, comprising extracorporeal adsorption of growth factors from blood of the subject and return of the treated blood to the subject. | 05-27-2010 |
| 20100185133 | MULTI-TREATMENT PLANNING APPARATUS AND METHOD - A treatment planning apparatus ( | 07-22-2010 |
| 20100198130 | Method and Apparatus for Producing Autologous Clotting Components - A method and apparatus for obtaining various components of a multi-component material. Generally, a component of a whole blood sample may be concentrated from a patient and re-introduced to the same patient. For example, a clotting component, such as thrombin, from a whole blood sample may be extracted and concentrated in an apparatus and collection to be reapplied or reintroduced into a patient. | 08-05-2010 |
| 20100217172 | Device, system, and method for controllably reducing inflammatory mediators in a subject - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-26-2010 |
| 20100217173 | Device, system, and method for controllably reducing inflammatory mediators in a subject - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Extracorporeal devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-26-2010 |
| 20100280430 | INFUSION APPARATUS - In an infusion apparatus, an infusion line ( | 11-04-2010 |
| 20100292627 | AIR SEPARATOR FOR EXTRACORPOREAL FLUID TREATMENT SETS - An air separator ( | 11-18-2010 |
| 20110046534 | DEVICE AND METHOD FOR MONITORING AN ACCESS TO A PATIENT, IN PARTICULAR A VASCULAR ACCESS DURING AN EXTRACORPOREAL BLOOD TREATMENT - The invention relates to the monitoring of an access to a patient at a puncture point, in particular the monitoring of the arterial and/or venous vascular access during an extracorporeal blood treatment. The device according to the invention is a magnetoelastic moisture sensor, which is embedded in an absorbent material and is laid on the puncture point. For the case in which infusion solution and/or blood exits from the puncture point, the incorrect seating of the puncture cannula can be recognized reliably using the device according to the invention. The absorbent material having the embedded magnetoelastic moisture sensor can be laid like conventional bandage material or a gauze bandage on the puncture point. | 02-24-2011 |
| 20110054378 | Methods and Systems for Measuring and Verifying Additives for Use in a Dialysis Machine - The present application discloses a portable dialysis system for conducting a dialysis treatment. The portable dialysis system has a controller unit that includes a display, a scale, a bar code reader, and a memory storing a plurality of programmatic instructions. Upon execution, the instructions generate a first graphical user interface, a second graphical user interface, and a third graphical user interface for presentation on the display. The first graphical user interface displays each additive required for use in the dialysis treatment. The second graphical user interface prompts a user to submit additives to scanning using the bar code scanner. The third graphical user interface prompts a user to submit additives to measurement using the scale. | 03-03-2011 |
| 20110105979 | PATIENT TREATMENT AND MONITORING SYSTEMS AND METHODS - The invention provides apparatus and methods for home or other remote delivery of health care that gather subjective and objective measures of patient health and treatment, analyzing them (e.g., correlating them with one another and/or with norms) and reporting them to aid in on-going patient diagnosis and treatment (both on acute and chronic bases), as well as to aid physicians, nurses and other caregivers in decision support, monitoring treatment compliance, facilitating regulatory compliance, billing, and so forth. Thus, for example, in some aspects a health care delivery device comprising a medical treatment apparatus, such as a home hemodialysis or home peritoneal dialysis unit, that is coupled to a processor. The processor generates patient queries in connection with treatments rendered by the dialysis equipment (or other treatment apparatus). The queries are directed, at least in part, to subjective topics, such as the state of the patient's mental health and well being, quality of life, degrees of pain, views on success of therapy, and so forth. They are presented on an LCD screen or other output device coupled to the processor to elicit responses on a keyboard or other input device, also coupled to the processor. | 05-05-2011 |
| 20110105980 | TREATMENT OF THROMBOANGIITIS OBLITERANS BY REMOVAL OF AUTOANTIBODIES - The invention relates to the use of a specific ligand for antibodies, preferably autoantibodies in the manufacture of a column for the treatment of thromboangiitis obliterans. The invention pertains furthermore to the apharesis column with at least one anti-IgG antibody for the treatment of thromboangiitis obliterans. | 05-05-2011 |
| 20110208105 | METHOD FOR DETECTING THE ION CONCENTRATIONS OF CITRATE ANTI-COAGULATED EXTRACORPOREAL BLOOD PURIFICATION - The invention relates to a device for the citrate anti-coagulated extracorporeal blood purification comprising: an extracorporeal blood purification system comprising an extracorporeal blood circuit ( | 08-25-2011 |
| 20110230813 | Process for Metabolic Control and High Solute Clearance and Solutions for Use Therein - The present disclosure describes novel standardized citrate replacement fluid solutions and a standardized dialysate solution for use with CRRT methods. The standardized citrate replacement fluid solutions and standardized dialysate solutions do not require modification based on the clinical status of the individual patients. The use of the standardized solutions described herein offers significant advantages over the prior art solutions used in CRRT. The present disclosure describes superior metabolic and electrolyte control and significantly increased dialyzer patency in: (a) 24 intensive care unit (ICU) patients with ARF using a 0.67% trisodium citrate replacement fluid solution, and (b) 32 ICU patients with ARF using a 0.5% trisodium citrate replacement fluid solution. Both groups were treated with Bicarbonate-25 dialysate and achieved effluent rates of 35 mL/kg/hr. | 09-22-2011 |
| 20110245750 | METHOD AND APPARATUS FOR ACOUSTICALLY ENHANCED REMOVAL OF BUBBLES FROM A FLUID - A vessel for removing bubbles from a fluid is provided. The vessel includes a fluid inlet port for receiving the fluid and a bubble outlet for removing bubbles in the fluid from the vessel. One or more ultrasonic transducers transmit one or more ultrasonic beams through the received fluid to move bubbles in the fluid towards the bubble outlet. A fluid outlet port outputs the fluid insonified by the one or more ultrasonic beams. A conduit structure conveys the one or more ultrasonic beams through the vessel in a first direction towards the air outlet. An interface prevents reflection of one or more ultrasonic beams in a direction generally opposite the first direction. | 10-06-2011 |
| 20110295175 | Sequential Extracoporeal Treatment of Bodily Fluids - An article and method to treat extracorporeally a patient's bodily fluid. The bodily fluid can include blood, cerebral spinal fluid and lymph. A first stage of the method includes applying a treatment. The treatment can comprise dosing with a medication, thermal treatment, or irradiation. The treatment can occur at levels that could otherwise compromise the patient's health. A second stage of the method substantially removes the treatment from the bodily fluid. The bodily fluid can then be returned to the patient. The article includes a treatment chamber that applies the treatment and a removal module for removing the treatment. The method can be a continuous process such as, for example, a dialysis process. | 12-01-2011 |
| 20110306913 | BEARING AND BEARING ASSEMBLY FOR UMBILICUS OF A FLUID PROCESSING SYSTEM - A one-piece bearing is provided for use with a fluid processing assembly of the type having an umbilicus, a bearing support, a gimbal received within the bearing support, and a liner at least partially received within the gimbal. The bearing is secured to a midsection of the umbilicus and adapted to be at least partially received within the liner. An inner surface of the bearing engages the umbilicus while an outer surface of the bearing engages at least a portion of the liner for rotation relative to the liner. | 12-15-2011 |
| 20120059303 | Low Flow Optical Blood Chamber - A low flow blood chamber for optically monitoring blood flowing through extracorporeal tubing has a flat elongated blood flow cavity but preserves the circular viewing area of conventional blood chambers. The blood chamber provides consistent, mixed flow through the blood cavity even at low blood flow rates, e.g. 10 to 500 ml/min., while maintaining certain dimensional characteristics of conventional blood chambers. | 03-08-2012 |
| 20120277650 | CARDIOVASCULAR MONITORING FOR FLUID REMOVAL PROCESSES - A method includes initiating a blood fluid removal session for a patient in need thereof; monitoring a cardiovascular parameter of the patient; determining whether the indicator of the cardiovascular state crosses a predetermined threshold; and altering a parameter of the blood fluid removal session if the indicator is determined have crossed the threshold. | 11-01-2012 |
| 20130030344 | METHOD AS WELL AS APPARATUSES FOR REMOVING GAS ACCUMULATIONS FROM A COMPONENT OF AN EXTRACORPOREAL BLOOD CIRCUIT - The present invention relates to a method for removing gas accumulations from a component of an extracorporeal blood circuit, a control device for executing a method according to the present invention, a medical treatment apparatus which comprises at least one control device and/or stands in signal transmission or is connected for signal transmission with it, a digital storage medium, a computer program product as well as a computer program. | 01-31-2013 |
| 20130046224 | METHOD AND APPARATUS FOR THE DIALYSIS OF BLOOD - Apparatus for use in dialyzing a patient comprising a hemodialysis catheter comprising an elongated body having a proximal and a distal end, wherein the distal end terminates in a substantially planar distal end surface; first and second lumens extending from the proximal end to the distal end, wherein the lumens terminate on the distal end surface in first and second mouths, arranged in side-by-side configuration, and further wherein the lumens are separated by a septum; and first and second longitudinal slots formed in the distal end of the elongated body and communicating with the interiors of the lumens, the slots opening on the distal end surface; wherein the slots each have a length and a width, relative to the dimensions of the lumens and the rate of blood flow to be passed through the hemodialysis catheter, so as to minimize undesirable recirculation of dialyzed blood. | 02-21-2013 |
| 20130197417 | DEVICE, SYSTEM, AND METHOD FOR CONTROLLABLY REDUCING INFLAMMATORY MEDIATORS IN A SUBJECT - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Extracorporeal devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-01-2013 |
| 20130226065 | DIALYSATE PROFILING CONTROLLED BY UV MONITORING - The invention relates to a method and an apparatus for the determination of removed uremic substances from an extracorporeal blood circulation and for an adjustment of flow controlled according to this data. The method according to the invention is used for the optimization of the consumption as well as the use of a volume of dialysate. | 08-29-2013 |
| 20130267883 | METHOD, APPARATUS, AND SYSTEM FOR TREATMENT OF BLOOD OF A PATIENT - The present invention relates to a method for treating the blood of a patient, comprising removing water from the blood of patients at a settable water removal rate, wherein the position of the patient is determined and the water removal rate is set, controlled, and/or regulated depending on the determined position of the patient. The invention further relates to an apparatus for treating the blood of a patient, comprising a blood treatment device for removing water from the blood of the patient at a settable water removal rate, wherein position-determining means for determining the position of the patient, wherein the water removal rate is settable, regulatable, and/or controllable depending on the determined position of the patient. | 10-10-2013 |
| 20130274642 | MULTIMODAL DIALYSIS SYSTEM - A dialysis device for operation in multiple modes and for maintaining a known gradient of potassium ion or other electrolyte between the blood of a patient and a dialysate fluid is described. The dialysis device is capable of being used for hemodialysis or peritoneal dialysis, and the dialysis device is capable of operation with a dialysate purification unit outside of a clinical setting or with a supply of water that can be supplied in a clinical setting. The dialysis device has a composition sensor containing a potassium-sensitive electrode for measuring a potassium ion concentration in one or more of the patient's blood and the dialysate fluid and an infusate pump operated to adjust a potassium ion concentration in the dialysate fluid based at least in part on data from the composition sensor. | 10-17-2013 |
| 20130274643 | ARTERIAL DEVICE, SYSTEM AND METHOD FOR REMOVING EMBOLIC DEBRIS - An arterial device, system and method are provided for use with a patient undergoing a cardiac procedure. The system is configured for enabling one or more arterial devices to be accommodated in the aorta of the patient in use of the system, and a perfusion lumen arrangement provides therethrough a target perfusion flow into the aorta having a target perfusion flow rate that is significantly greater than a nominal perfusion flow rate, by an excess perfusion flow rate. A suction lumen arrangement provides therethrough a suction flow out of the aorta at a suction flow rate. The target perfusion flow rate and the suction flow rate may be concurrently and selectively controlled to cause embolic debris that may be present in the aorta to be diverted to the suction inlet, while providing the nominal flow rate to the body circulation of the patient. | 10-17-2013 |
| 20130303959 | Arteriovenous Access Valve System and Process - An arteriovenous graft system is described. The arteriovenous graft system includes an arteriovenous graft that is well suited for use during hemodialysis. In order to minimize or prevent arterial steal, at least one valve device is positioned at the arterial end of the arteriovenous graft. In one embodiment, a subcutaneous arteriovenous graft system is described. The system includes an arteriovenous graft having an arterial end and an opposite venous end with a first valve device positioned at the arterial end of the arteriovenous graft and a second valve device positioned at the venous end of the arteriovenous graft. The system also includes an actuator having an accumulator. The actuator is in communication with both the first valve device and the second valve device and is configured to cause each valve device to open or close simultaneously. The accumulator assists in maintaining a generally constant pressure when the actuator causes each valve device to close. | 11-14-2013 |
| 20140031736 | MAGNETIC SENSORS AND RELATED SYSTEMS AND METHODS - This invention relates generally to magnetic sensors and related systems and methods. In some aspects of the invention, a magnetic sensor assembly includes a housing configured to releasably hold a medical fluid tube and a sensor secured to the housing, the sensor configured to detect a change in a strength of a magnetic field when a medical fluid passes through the medical fluid tube. | 01-30-2014 |
| 20140039373 | System and Method for Automated Separation of Whole Blood - An apparatus for separating whole blood includes an access device for drawing whole blood from a source, a blood component separation device, a draw line, a draw pump, and a controller. The blood component separation device separates the drawn whole blood into a first blood component and a second blood component. The draw line fluidly connects the access device and the blood component separation device, and the draw pump draws whole blood from the source through the access device and draw line and into the blood component separation device. The controller controls fluid flow through the apparatus and operation of the draw pump. The controller also monitors the total volume of whole blood drawn from the source and the total volume of first blood component collected. The controller stops the draw pump when the first of a target whole blood volume is withdrawn or a target volume of first blood component is collected. | 02-06-2014 |
| 20140148749 | GLUCOSE MANAGEMENT AND DIALYSIS METHOD AND APPARATUS - A process and apparatus are provided for managing and adjusting glucose levels in the blood of a patient during dialysis. The apparatus is a dialysis apparatus to treat patients with renal disease which includes a glucose scavenger to remove excess glucose from the blood before returning the blood to the patient and/or a device to increase blood glucose levels in the blood when the glucose level is below a threshold level. The glucose scavenger can include a glucose binding protein, boronic acid derivative, boronic ester derivative or mixture thereof bonded to the surface of a support such as a fiber bundle in a cartridge or the inner surface of tubing used in the apparatus. | 05-29-2014 |
| 20140323942 | FUZZY LOGIC - The described system and method for blood treatment are configured to detect at least two hemodynamic parameters, for example the blood pressure and the relative blood volume, during the blood treatment. At least two fuzzy modules receive measuring values of the hemodynamic parameters as input variables, wherein the output signals transmitted by the fuzzy modules are weighted by at least one weighting module. A setting means effectuates setting of at least one variable, for example an ultrafiltration rate, a dialysis fluid conductivity or a dialysis fluid temperature, in response to the output signal transmitted by the weighting module. In this way, e.g. threatening intradialytic hypotensive episodes can be detected and avoided. The system can be designed as a dialyser for hemodialysis, hemofiltration or hemodiafiltration. | 10-30-2014 |
| 20150367054 | ELECTROLYTE AND pH MONITORING FOR FLUID REMOVAL PROCESSES - Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session. | 12-24-2015 |
